Cytox (AgeTech UK) NeuroTech
Cytox Group Limited provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway.
Connections from
Founded Date:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Technology:
AgeTech Companies
Investor Type:
N/A
Employee Number:
N/A
Funding Status:
N/A